{"nct_id":"NCT02223247","title":"A Phase 1, First-In-Human Study of Escalating Doses of Oral TVB-2640 in Patients With Solid Tumors","status":"COMPLETED","status_verified_date":"2017-08","start_date":"2013-11","start_date_type":null,"primary_completion_date":"2017-06","primary_completion_date_type":"ACTUAL","completion_date":"2017-06","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["SGMT"]}